AVEO PHARMACEUTICALS INC | 1,919 Euro | -0,028 -1,44 % | |
| WKN: A0YH9L ISIN: US0535881090 Ticker-Symbol: VPA | Frankfurt | 19.06.13 | 08:00 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 16.06. | Aveo Pharma Hanging By A Thread | 6 | Seeking Alpha | |
| 11.06. | AVEO Pharmaceuticals, Inc. - Special Call | 8 | Seeking Alpha | |
| 10.06. | AVEO PHARMACEUTICALS INC - 8-K, Current Report | 6 | SEC Filings | |
| 05.06. | AVEO Pharmaceuticals, Inc. - Special Call | 10 | Seeking Alpha | |
| 23.05. | AVEO PHARMACEUTICALS INC - 8-K, Current Report | 21 | SEC Filings | |
| 18.05. | Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm | 173 | PR Newswire | |
| NEW YORK, May 18, 2013 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or the "Company")... Mehr lesen zu: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm | ||||
| 17.05. | Aveo Pharmaceuticals, Inc. Sued by Investor | 128 | PR Newswire | |
| SAN DIEGO andCAMBRIDGE, Mass., May 17, 2013 /PRNewswire/ --Shareholder rights attorneysat Robbins Arroyo LLP announce that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has... Mehr lesen zu: Aveo Pharmaceuticals, Inc. Sued by Investor | ||||
| 12.05. | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) | 120 | Marketwired | |
| OKLAHOMA CITY, OK -- (Marketwired) -- 05/12/13 -- On May 9, 2013, a class action lawsuit was filed in the United States District Court for the District of Massachusetts against AVEO Pharmaceuticals... Mehr lesen zu: Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) | ||||
| 10.05. | Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc. | 155 | PR Newswire | |
| NEW YORK, May 10, 2013 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a securities class action has been commenced in the United States District Court for the District of Massachusetts... Mehr lesen zu: Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc. | ||||
| 06.05. | Zacks Bull and Bear of the Day Highlights: Private Bancorp, Pan American Silver, AVEO Pharmaceuticals, Astellas Pharma and Cleveland BioLabs | 70 | PR Newswire | |
| CHICAGO, May 6, 2013 /PRNewswire/ --Zacks Equity Research highlights Private Bancorp (Nasdaq:PVTB) as the Bull of the Day and Pan American Silver (Nasdaq:PAAS) as the Bear of the Day. In addition... Mehr lesen zu: Zacks Bull and Bear of the Day Highlights: Private Bancorp, Pan American Silver, AVEO Pharmaceuticals, Astellas Pharma and Cleveland BioLabs | ||||
| 03.05. | AVEO Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript | 20 | Seeking Alpha | |
| 03.05. | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aveo Pharmaceuticals, Inc. | 43 | PR Newswire | |
| NEW YORK, May 3, 2013 /PRNewswire/ --Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Aveo Pharmaceuticals... Mehr lesen zu: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aveo Pharmaceuticals, Inc. | ||||
| 03.05. | XFRA VPA: WIEDERAUFNAHME/RESTART | 75 | Xetra Newsboard | |
| DIE FOLGENDE AKTIE WIRD MIT SOFORTIGER WIRKUNG WIEDER IN DEN HANDEL
AUFGENOMMEN:
THE FOLLOWING SHARE IS RESUMED TRADING WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
AVEO PHARMACTCLS... Mehr lesen zu: XFRA VPA: WIEDERAUFNAHME/RESTART | ||||
| 03.05. | AVEO Spurned, ARNA Bleeds, It's Thumbs Up For AGN, OGXI Lists Busy Slate | 105 | AFX News | |
| FOSTER CITY (dpa-AFX) - Allergan Inc.'s (AGN) experimental device JUVÉDERM
VOLUMA XC, an injectable hyaluronic acid dermal filler for cheek augmentation to
correct age-related volume deficit... Mehr lesen zu: AVEO Spurned, ARNA Bleeds, It's Thumbs Up For AGN, OGXI Lists Busy Slate | ||||
| 02.05. | Why AVEO Pharmaceuticals Shares Were Eviscerated | 19 | Motley Fool | |
| 02.05. | AVEO PHARMACEUTICALS INC - 8-K, Current Report | 5 | SEC Filings | |
| 02.05. | BRIEF-AVEO Pharma shares resume trading, down 46 pct | 14 | Reuters.com | |
| 02.05. | JPMorgan stuft Aveo Pharmaceuticals von Overweight auf Neutral. | 97 | BörseGo | |
| JPMorgan stuft Aveo Pharmaceuticals von Overweight auf Neutral.
(© BörseGo AG 2013 - Autor: Simon Hauser, Redakteur) Mehr lesen zu: JPMorgan stuft Aveo Pharmaceuticals von Overweight auf Neutral. | ||||
| 02.05. | XFRA VPA: AUSSETZUNG/SUSPENSION | 118 | Xetra Newsboard | |
| DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT:
THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
AVEO PHARMACTCLS VPA US0535881090 BAW/UFN Mehr lesen zu: XFRA VPA: AUSSETZUNG/SUSPENSION | ||||
| 02.05. | AGEN's Brain Cancer Vaccine Works, AVEO On Watch, PSDV Gets Decision Date | 118 | AFX News | |
| OTTAWA (dpa-AFX) - Agenus Inc. (AGEN) said that its brain cancer vaccine
candidate - Prophage G-100, plus the standard of care demonstrated a 146%
increase in progression free survival and... Mehr lesen zu: AGEN's Brain Cancer Vaccine Works, AVEO On Watch, PSDV Gets Decision Date | ||||
Seite: 1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| VERTEX PHARMACEUTICALS | 58,92 | +1,43 % | Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals |
| CELGENE | 89,40 | +0,38 % | EC approves Celgene's Revlimid to treat myelodysplastic syndromes |
| ARIAD PHARMACEUTICALS | 13,25 | +1,43 % | Ariad's Iclusig in GIST Phase II Study |
| ELAN | 10,119 | +1,44 % | Elan macht Weg frei für Verkaufsprozess - Royalty Pharma soll sich beteiligen |
| STADA ARZNEIMITTEL | 33,85 | +0,30 % | DGAP-Stimmrechte: STADA Arzneimittel AG (deutsch) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von